GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr | ₹14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-38 Cr |
| Mar2024 | ₹389 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹255 Cr |
| Mar2021 | ₹14 Cr |
How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-38 Cr | Negative | |
| Mar2024 | ₹389 Cr | 1,902.17 | |
| Mar2023 | ₹19 Cr | -92.37 | |
| Mar2022 | ₹255 Cr | 1,695.19 | |
| Mar2021 | ₹14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,991.7 Cr | 3.3% | 7.3% | 32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3.3% |
7.3% |
32.7% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses